Cellebrite DI Ltd.
12.10USD
+0.3100 (+2.63%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on CLBT.
| In $M except per-share | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|
| Revenue | 128 | 129 | 126 | 113 | 108 |
| Cost of Revenue | 22 | 20 | 20 | 18 | 17 |
| Gross Profit | 106 | 109 | 106 | 96 | 90 |
| Operating Income | 9 | 21 | 19 | 14 | 12 |
| Net Income | 11 | 21 | 20 | 19 | 17 |
| EPS (Diluted) | $0.04 | $0.08 | $0.08 | $0.08 | $0.07 |
Source: Yahoo Finance (limited history)